Former Xiaomi executive Wang Teng has raised more funds: entering the smart sleep industry

```

News on May 12th: Sleep health technology company "Today Rest Recommended" has recently completed a new round of financing.

It is understood that this round of financing introduced CMC Capital, Honghui Fund, and Junli Capital, while Hillhouse Ventures, Yunjiu Capital, and Lingzhi Fund, as existing investors, continued to invest in excess. This is also the company’s second public capital activity within only five months of its founding.

Given the cautious environment for consumer electronics and hardware/software startups in today's primary market, a startup able to consecutively secure cross-investments from top VCs, major consumer funds, and medical health specialty funds indirectly reflects the capital market’s revaluation of the niche “AI+ health intervention” track.

Today Rest Recommended was founded in January 2026 by former Xiaomi executive Wang Teng, with its core founding team primarily coming from top tech companies such as Xiaomi and Huawei.

From an industry analysis perspective, this organizational structure makes the company’s initial core barrier not simply basic medical research, but rather engineering implementation capabilities and cost structure control built upon a mature consumer electronics supply chain.

Unlike other sleep health companies focusing solely on digital therapies or software apps, a team with big tech hardware genes is more inclined to use physical hardware as the endpoint anchor for data collection, attempting to realize a complete business loop of “physical hardware acquiring physiological data, AI algorithm cloud processing, and multimodal feedback intervention.”

This path from simple “sleep monitoring” to “physical intervention” has long been hinted at in the lineup of industrial investors in its past financing rounds.

In the seed round of tens of millions of yuan this January, leading traditional mattress company Xilimen and embodied intelligence company ZhiYuan Robotics were both among the investors.

This investment structure with strong industry implications suggests that the upcoming products from Today Rest Recommended are very unlikely to be limited to a single wearable wristband, but may cover a comprehensive hardware matrix from physical monitoring of sleep environments to coordinated multi-dimensional sensors, aiming to solve the industry pain point of traditional sleep monitoring devices that “only measure, but don’t treat.”

In terms of market strategy, Today Rest Recommended has clarified its plan to gradually launch a series of smart hardware/software products in the second half of this year, and has established global expansion as its strategic focus.

This choice is rooted in practical financial considerations. Currently, domestic smart wearable and sleep health devices are prone to homogenous price wars, whereas overseas markets like Europe and the US have significantly higher willingness to pay and unit prices for sleep improvement services, such as consumer-grade devices integrating cognitive behavioral therapy. Entering these high-potential markets via a global strategy helps optimize the company’s early financial model and raise profit margin ceilings.

Multiple funds investing in quick succession usually means the company has outperformed investor expectations in certain R&D milestones or early gray-scale tests. Capital’s continued investment at this point is mainly based on structural changes in the track and predictions of future moats.

With the evolution of large-model technologies, AI’s ability to process continuous biological rhythm data such as temperature, heart rate variability, and breathing frequency has advanced from basic chart displays to providing personalized dynamic intervention solutions.

The involvement of funds like Honghui, which have medical backgrounds, also confirms that the market expects a certain level of seriousness in the company’s health management data.

Furthermore, pure software sleep apps easily face high user churn rates, whereas hardware as a physical medium increases sunk costs, indirectly boosting user retention and activity. Combined with the management’s past experience in defining C-end products, integrating supply chains, and global marketing, the startup’s error costs during hardware mass-production are effectively lowered.

However, if Today Rest Recommended wants to truly occupy terminal entry points in the sleep economy worth tens of billions, it must still face tough reality checks in the second half of the year.

Smart health hardware always walks the line between consumer electronics and medical devices. If positioned as consumer-grade products, the company faces the risk of being outcompeted by giants like Apple and Huawei, who possess ecosystems and huge user bases; seeking medical-grade certification, however, means lengthy compliance approval processes and clinical trials in various countries, delaying commercialization and placing harsh demands on cash flow.

More importantly, improving sleep is a long-term behavioral change; whether AI hardware intervention can deliver significant and perceptible real efficacy to users—thus supporting product repurchase or subsequent software subscription income—remains an unresolved question.

Today Rest Recommended, through rapid financing, has laid a solid foundation, but whether its software-hardware coordinated business story can truly close the loop will ultimately be answered by its mass-produced products and real commercialization data soon to be delivered.

Risk Warning and DisclaimerThe market bears risks, investment requires caution. This article does not constitute personal investment advice, nor does it take into account individual users’ special investment objectives, financial situations, or needs. Users should consider whether any opinions, viewpoints, or conclusions in this article fit their particular circumstances. Invest accordingly, at your own risk. ```